Brief: Adocia Announces Successful Phase 1 Study For Biochaperone Lispro With Partner Tonghua Dongbao

Adocia SA

29/12/2022 07:02

Dec 29 (Reuters) - Adocia SA  ADOC.PA :
    * ADOCIA ANNOUNCES THE SUCCESSFUL PHASE 1 STUDY FOR
BIOCHAPERONE®
LISPRO WITH PARTNER TONGHUA DONGBAO
    * DOCIA'S PARTNER, TONGHUA DONGBAO, ANNOUNCED THAT PRIMARY
ENDPOINT OF THIS PHASE 1 STUDY WAS REACHED, AND RESULTS
CONFIRMED ACCELERATED PROFILE OF BIOCHAPERONE LISPRO IN
COMPARISON TO LISPRO
    * ONGOING PHASE 3 STUDIES ARE ONLY REMAINING CLINICAL
ACTIVITIES
PLANNED BEFORE SUBMITTING MARKETING AUTHORIZATION FILE TO
CHINESE REGULATORY AUTHORITIES
    * BIOCHAPERONE LISPRO IS EXPECTED TO BE FIRST ANALOG OF
ULTRA-RAPID INSULIN TO BE MARKETED IN CHINA BY A CHINESE COMPANY

Source text for Eikon:  ID:nBw1KVh2sa 
Further company coverage:  ADOC.PA 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))